Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways

BACKGROUND: Many chronic metabolic diseases, such as obesity and type 2 diabetes (T2DM), are closely related to a chronic low-grade inflammatory state in tissues. The high prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with T2DM is related to the role of inflammation in the dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Ying, Yang, Pijian, Li, Zhengming, Luo, Yunchen, Shen, Jing, Li, Ruwen, Zheng, Hua, Liang, Yuzhen, Xia, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896910/
https://www.ncbi.nlm.nih.gov/pubmed/31819375
http://dx.doi.org/10.2147/DDDT.S224688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896910/
https://www.ncbi.nlm.nih.gov/pubmed/31819375
http://dx.doi.org/10.2147/DDDT.S224688

Ejemplares similares